Small peptide WNWKL and Scabraside D Compound of Sea Cucumber Might Inhibit NFκB: Implication on Their Anti-inflammatory and Anticancer Potentials
DOI:
https://doi.org/10.26538/tjnpr/v8i3.24Keywords:
small peptide, sea cucumber, Scabraside D, nuclear factor-kappaBAbstract
Myriad studies have shown that sea cucumber is a promising anti-inflammatory and anticancer agent. Therefore, a study to identify the active compounds contained in sea cucumber, which have the potential as nuclear factor kappa-light-chain-enhancer of activated B cell (NFκB) inhibitors was conducted. NFκB plays a significant role in regulating inflammation and carcinogenesis, so the inhibition of NFκB activity by active compounds from sea cucumber hold the potential to be further investigated as anti-inflammatory and anticancer agents. This research was carried out in silico with various tools including molecular docking and molecular dynamics to determine the inhibitor potential of sea cucumber compounds. Small peptides and other active compounds from sea cucumbers were collected from various references, and then, using bioinformatic tools, their tertiary structures were modeled. The structure of NFκB was obtained from the Protein Data Bank. The results of this study show that small peptide WNWKL and Scabraside D may bind to the active site of the NFκB protein, similar to the binding site of caffeic acid phenethyl ester, utilized as a positive control for NFκB inhibitors. The dynamic molecular result analysis also shows that the two active compounds can form stable complexes with NFκB for up to 70 ns. These findings predict that small peptide WNWKL and Scabraside D can be NFκB inhibitors, rendering them promising candidates for further analysis as anti-inflammatory and anticancer agents.
References
Xia Y, Shen S, Verma IM. NF-κB, an active player in human cancers. Cancer Immunol Res. 2014; 2(9):823–830.
Li F, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Kumar AP, Ahn KS, Sethi G. NF-κB in cancer therapy. Arch Toxicol. 2015; 89(5):711–731.
Nennig SE, Schank JR. The role of NFkB in drug addiction: Beyond inflammation. Alcohol Alcohol. 2017; 52(2):172–179.
Erstad DJ, Cusack JC. Targeting the NF-κB pathway in cancer therapy. Surg Oncol Clin N Am. 2013; 22(4):705–746.
Lin Y, Bai L, Chen W, Xu S. The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets. 2010; 14(1):45–55.
Jana A, Krett NL, Guzman G, Khalid A, Ozden O, Staudacher JJ, Bauer J, Baik SH, Carroll T, Yazici C. NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway. Oncotarget. 2017; 8(23):37377–37393.
Fedorov SN, Dyshlovoy SA, Kuzmich AS, Shubina LK, Avilov SA, Silchenko AS, Bode AM, Dong Z, Stonik VA. In vitro anticancer activities of some triterpene glycosides from holothurians of cucumariidae, stichopodidae, psolidae, holothuriidae and synaptidae families. Nat Prod Commun. 2016; 11(9):1239–1242.
Zhao Q, Xue Y, Wang JF, Li H, Long TT, Li Z, Wang YM, Dong P, Xue CH. In vitro and in vivo anti-tumour activities of echinoside A and ds-echinoside A from Pearsonothuria graeffei. J Sci Food Agric. 2012;92(4):965–74.
Zhao Q, Liu ZD, Xue Y, Wang JF, Li H, Tang QJ, Wang YM, Dong P, Xue CH. Ds-echinoside A, a new triterpene glycoside derived from sea cucumber, exhibits antimetastatic activity via the inhibition of NF-κB-dependent MMP-9 and VEGF expressions. J Zhejiang Univ Sci B. 2011; 12(7):534–544.
Park SY, Kim YH, Kim Y, Lee SJ. Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-κB and AP-1 signaling in human breast cancer cells. Int J Oncol. 2012;41(3):933–40.
Zhao Q, Xue Y, Liu ZD, Li H, Wang JF, Li ZJ, Wang YM, Dong P, Xue CH. Differential effects of sulfated triterpene glycosides, holothurin A1, and 24-dehydroechinoside A, on antimetastasic activity via regulation of the MMP-9 signal pathway. J Food Sci. 2010;75(9).
Bordbar S, Anwar F, Saari N. High-value components and bioactives from sea cucumbers for functional foods—A review. Mar Drugs. 2011 ;9(10):1761–1805.
Cuong NX, Vien LT, Hoang L, Hanh TTH, Thao DT, Thanh NV, Nam NH, Thung DC, Kiem PV, Minh CV. Cytotoxic triterpene diglycosides from the sea cucumber Stichopus horrens. Bioorganic Med Chem Lett. 2017; 27(13):2939–42.
Shahinozzaman M, Ishii T, Takano R, Halim MA, Hossain MA, Tawata S. Cytotoxic desulfated saponin from Holothuria atra predicted to have high binding affinity to the oncogenic kinase PAK1: A combined in vitro and in silico study. Sci Pharm. 2018; 86(3):1–13.
Kareh M, El-Nahas R, Al-Aaraj L, Al-Ghadban S, Al Deen NN, Saliba N, El-Sabban M, Talhouk R. Anti-proliferative and anti-inflammatory activities of the sea cucumber Holothuria polii aqueous extract. SAGE Open Med. 2018; 6:2050312118809541.
Pranoto D, Ratnawati H, Wargasetia TL, Octavallen A, Rachmat MAA. Sea cucumber reduces breast cancer tumor size through inhibition of MMP9 dependent HER2 expression in breast cancer mice model. Trop J Nat Prod Res. 2023; 7(9):4010–4015.
Wargasetia TL, Ratnawati H, Widodo N, Widyananda MH. Antioxidant and anti-inflammatory activity of sea cucumber (Holothuria scabra) active compounds against KEAP1 and iNOS protein. Bioinform Biol Insights. 2023; 17:1–10.
Olivera-Castillo L, Grant G, Kantún-Moreno N, Barrera-Pérez HA, Montero J, Olvera-Novoa MA, Carrillo-Cocom LM, Acevedo JJ, Puerto-Castillo C, May Solís V, Pérez-Vega JA, Gil-Zamorano J, Hernández-Garibay E, Fernández-Herrera MA, Pérez-Tapia M, Medina-Contreras O, Villanueva-Toledo JR, Rodriguez-Canul R, Dávalos A. A glycosaminoglycan-rich fraction from sea cucumber Isostichopus badionotus has potent. Nutrients. 2020;12(1698):1–15.
Shishodia S, Aggarwal BB. Nuclear factor-κB: A friend or a foe in cancer? Biochem Pharmacol. 2004;68(6):1071–80.
Müller CW, Rey FA, Sodeoka M, Verdine GL, Harrison SC. Structure of the NF-kappa B p50 homodimer bound to DNA. Nature. 1995; 373(6512):311–317.
Zhang Y, He S, Bonneil É, Simpson BK. Generation of antioxidative peptides from Atlantic sea cucumber using alcalase versus trypsin: In vitro activity, de novo sequencing, and in silico docking for in vivo function prediction. Food Chem. 2020; 306:125581.
Wargasetia T, Permana S, Widodo N. The role of sea cucumber active compound and its derivative as an anti-cancer agent. Curr Pharmacol Reports. 2018; 4.
Ali A, Shah FA, Zeb A, Malik I, Alvi AM, Alkury LT, Rashid S, Hussain I, Ullah N, Khan A, Koh PO, Li S. NF-κB inhibitors attenuate MCAO induced neurodegeneration and oxidative stress—a reprofiling approach. Front Mol Neurosci. 2020; 13:33.
Shityakov S, Förster C. In silico predictive model to determine vector-mediated transport properties for the blood–brain barrier choline transporter. Adv Appl Bioinform Chem. 2014; 7:23–36.
Krieger E, Vriend G. YASARA View - molecular graphics for all devices - from smartphones to workstations. Bioinformatics. 2014;30(20):2981–2.
Gupta SC, Sundaram C, Reuter S, Aggarwal BB. Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta. 2010;1799(10–12): 775–787.
Philip S, Kundu G. Osteopontin induces nuclear fctor κB-mediated promatrix metalloproteinase-2 activation through IκBα/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem. 2003; 278(16):14487–14497.
Sakamoto K, Maeda S. Targeting NF-κB for colorectal cancer. Expert Opin Ther Targets. 2010;14(6): 593–601.
Wargasetia TL, Ratnawati H, Widodo N. Sea cucumber compounds targeting NF-κB in cancer treatment. Bioinform Biol Insights. 2022;16: 11779322221091740.
Gupta SC, Kunnumakkara AB, Aggarwal S, Aggarwal BB. Inflammation, a double-edge sword for cancer and other age-related diseases. Front Immunol. 2018; 9:5–10.
Del Prete A, Allavena P, Santoro G, Fumarulo R, Corsi MM, Mantovani A. Molecular pathways in cancer-related inflammation. Biochem Medica. 2011; 21(3):264–275.
Martins GR, Gelaleti GB, Moschetta MG, Maschio-Signorini LB, Zuccari DAP de C. Proinflammatory and anti-inflammatory cytokines mediated by NF-κB factor as prognostic markers in mammary tumors. Mediators Inflamm. 2016:e9512743.
Gilmore TD, Herscovitch M. Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene. 2006; 25(51):6887–6899.
Widyananda MH, Wicaksono ST, Rahmawati K, Puspitarini S, Ulfa SM, Jatmiko YD, Masruri M, Widodo N. A potential anticancer mechanism of finger root (Boesenbergia rotunda) extracts against a breast cancer cell line. Scientifica (Cairo). 2022; 9130252.
Wargasetia TL, Ratnawati H, Widodo N, Widyananda MH. Bioinformatics study of sea cucumber peptides as antibreast cancer through inhibiting the activity of overexpressed protein (EGFR, PI3K, AKT1, and CDK4). Cancer Inform. 2021; 20: 11769351211031864.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Tropical Journal of Natural Product Research (TJNPR)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
